F. Giménez

746 total citations
26 papers, 572 citations indexed

About

F. Giménez is a scholar working on Public Health, Environmental and Occupational Health, Pharmacology and Pharmacology. According to data from OpenAlex, F. Giménez has authored 26 papers receiving a total of 572 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Public Health, Environmental and Occupational Health, 6 papers in Pharmacology and 6 papers in Pharmacology. Recurrent topics in F. Giménez's work include Malaria Research and Control (12 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Mosquito-borne diseases and control (5 papers). F. Giménez is often cited by papers focused on Malaria Research and Control (12 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Mosquito-borne diseases and control (5 papers). F. Giménez collaborates with scholars based in France, Canada and Thailand. F. Giménez's co-authors include Robert Farinotti, Caroline S. Fernandez, Paco Pino, Dominique Mazier, Jacques Le Bras, Catherine Gillotin, A. Thuillier, François Nosten, Nicholas J. White and Irving W. Wainer and has published in prestigious journals such as Cellular and Molecular Life Sciences, International Journal of Pharmaceutics and American Journal of Tropical Medicine and Hygiene.

In The Last Decade

F. Giménez

24 papers receiving 547 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
F. Giménez France	15	232	147	98	93	87	26	572
J.R. Kiechel France	13	67 0.3×	182 1.2×	92 0.9×	57 0.6×	111 1.3×	27	516
E T Lin United States	17	116 0.5×	128 0.9×	71 0.7×	67 0.7×	191 2.2×	23	946
François Gimenez France	20	96 0.4×	133 0.9×	266 2.7×	150 1.6×	111 1.3×	28	767
Te‐Yu Hung Taiwan	15	441 1.9×	119 0.8×	62 0.6×	26 0.3×	158 1.8×	33	804
A E Duncan United States	11	220 0.9×	63 0.4×	51 0.5×	31 0.3×	125 1.4×	14	569
Pekka Suhonen Finland	14	124 0.5×	36 0.2×	70 0.7×	58 0.6×	217 2.5×	24	609
Shang‐Ying P. King United States	13	28 0.1×	66 0.4×	99 1.0×	59 0.6×	221 2.5×	21	928
Jason Sousa United States	13	299 1.3×	151 1.0×	175 1.8×	13 0.1×	111 1.3×	26	641
Ulf Renner Germany	11	53 0.2×	48 0.3×	53 0.5×	64 0.7×	137 1.6×	16	554
Mark G. Eller United States	17	47 0.2×	80 0.5×	69 0.7×	17 0.2×	208 2.4×	34	749

Countries citing papers authored by F. Giménez

Since Specialization

Citations

This map shows the geographic impact of F. Giménez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Giménez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Giménez more than expected).

Fields of papers citing papers by F. Giménez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Giménez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Giménez. The network helps show where F. Giménez may publish in the future.

Co-authorship network of co-authors of F. Giménez

This figure shows the co-authorship network connecting the top 25 collaborators of F. Giménez. A scholar is included among the top collaborators of F. Giménez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Giménez. F. Giménez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mourelle, M, et al.. (2011). Treatment with LA-419 prevents monocrotaline-induced pulmonary hypertension and lung injury in the rat.. PubMed. 54. 89–93. 1 indexed citations

Giménez, F., et al.. (2005). L’insuffisance cardiaque. 1(1). 12–14.

Giménez, F., et al.. (2003). Tumor necrosis factor ? in the pathogenesis of cerebral malaria. Cellular and Molecular Life Sciences. 60(8). 1623–1635. 3 indexed citations

Giménez, F., et al.. (2003). Tumor necrosis factor alpha in the pathogenesis of cerebral malaria.. PubMed. 60(8). 1623–35. 110 indexed citations

Baune, Bruno, Jean-Pierre Flinois, V. Furlan, et al.. (1999). Halofantrine Metabolism in Microsomes in Man: Major Role of CYP 3A4 and CYP 3A5. Journal of Pharmacy and Pharmacology. 51(4). 419–426. 26 indexed citations

Giménez, F., et al.. (1998). Paciente con síndrome de Pearson y de Kearns-Sayre y la deleción común de 4, 9 Kb del ADN mitocondrial en sangre. Anales de Pediatría. 49(5). 510–512.

Thuillier, A., et al.. (1998). Determination of the enantiomers of chlorpheniramine and its main monodesmethyl metabolite in urine using achiral–chiral liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 707(1-2). 235–240. 21 indexed citations

Luxemburger, C., Al Brockman, K Silamut, et al.. (1998). Two patients with falciparum malaria and poor in vivo responses to artesunate. Transactions of the Royal Society of Tropical Medicine and Hygiene. 92(6). 668–669. 33 indexed citations

Baune, Bruno, et al.. (1997). Stereoselective Passage of Mefloquine Through the Blood-Brain Barrier in the Rat. Journal of Pharmacy and Pharmacology. 49(11). 1086–1090. 54 indexed citations

10.

Giménez, F., et al.. (1996). Uptake of mefloquine enantiomers into uninfected and malaria-infected erythrocytes.. Drug Metabolism and Disposition. 24(6). 689–691. 6 indexed citations

11.

Martin‐Chouly, Corinne, et al.. (1996). Stereoselective pharmacokinetics of mefloquine in young children. European Journal of Clinical Pharmacology. 50(3). 241–244. 17 indexed citations

12.

Bouchaud, Olivier, Léonardo K. Basco, Catherine Gillotin, et al.. (1994). Clinical Efficacy and Pharmacokinetics of Micronized Halofantrine for the Treatment of Acute Uncomplicated Falciparum Malaria in Nonimmune Patients. American Journal of Tropical Medicine and Hygiene. 51(2). 204–213. 18 indexed citations

13.

Martin‐Chouly, Corinne, F. Giménez, Kesara Na Bangchang, et al.. (1994). Whole blood concentrations of mefloquine enantiomers in healthy Thai volunteers. European Journal of Clinical Pharmacology. 47(1). 85–7. 15 indexed citations

14.

Giménez, F., Catherine Gillotin, Léonardo K. Basco, et al.. (1994). Plasma concentrations of the enantiomers of halofantrine and its main metabolite in malaria patients. European Journal of Clinical Pharmacology. 46(6). 561–562. 21 indexed citations

15.

Basco, Léonardo K., et al.. (1994). In vitro activity of the enantiomers of N-desbutyl derivative of halofantrine.. PubMed. 45(1). 45–6. 6 indexed citations

16.

Fernandez, Christine, et al.. (1993). Pharmacokinetics of zopiclone and its enantiomers in Caucasian young healthy volunteers.. Drug Metabolism and Disposition. 21(6). 1125–1128. 42 indexed citations

17.

Giménez, F., C. Dumartin, Irving W. Wainer, & Robert Farinotti. (1993). Improved column-switching liquid chromatographic method for the determination of the enantiomers of mefloquine. Journal of Chromatography B Biomedical Sciences and Applications. 619(1). 161–166. 10 indexed citations

18.

Gillotin, Catherine, et al.. (1992). In vitro activity of the enantiomers of mefloquine, halofantrine and enpiroline against Plasmodium falciparum.. British Journal of Clinical Pharmacology. 33(5). 517–520. 56 indexed citations

19.

Basco, Léonardo K., Catherine Gillotin, F. Giménez, Robert Farinotti, & Jacques Le Bras. (1991). Absence of antimalarial activity or interaction with mefloquine enantiomers in vitro of the main human metabolite of mefloquine. Transactions of the Royal Society of Tropical Medicine and Hygiene. 85(2). 208–209. 12 indexed citations

20.

Giménez, F., et al.. (1988). Study of thiorphan degradation. International Journal of Pharmaceutics. 43(1-2). 23–30. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact